Back to Results
First PageMeta Content
GlaxoSmithKline / Asthma / Phenethylamines / Organofluorides / Fluticasone/salmeterol / Salmeterol / Fluticasone propionate / Inhaler / Salbutamol / Pulmonology / Medicine / Respiratory therapy


Rapporteur’s Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Seretide Evohaler/Viani Evohaler, Seretide Diskus/Viani
Add to Reading List

Document Date: 2011-01-05 07:16:25

Open Document

File Size: 226,97 KB

Share Result on Facebook

Company

SLM / GlaxoSmithKline / Pharmacotherapeutic Group / /

Country

United Kingdom / Sweden / /

/

Facility

Seretide Diskus/Viani Diskus Seretide Evohaler INN / /

IndustryTerm

medicinal product / combination product / /

MedicalCondition

Asthma Salmeterol/Fluticasone / COPD / bronchial asthma / rash / severe asthma / asthma / /

Organization

European Union / /

Person

Eva Agurell / Eva Gil Berglund / /

/

Position

Prime Minister / /

Product

fluticasone propionate / albuterol / beta-2 / /

Technology

Pharmacokinetics / genotype / /

SocialTag